Gastrointestinal capacity, gut hormones and appetite change during rat pregnancy and lactation

Reproduction : the Official Journal of the Society for the Study of Fertility
Michelle L JohnsonVictoria J Taylor

Abstract

Pregnancy and lactation increase maternal appetite and adiposity, which in humans can lead to long-term body mass retention. Previous rat reproduction studies suggest that appetite-inhibiting gut hormone, peptide-YY (PYY), is elevated, despite hyperphagia also that gastrointestinal size increases. The present study characterised changes in orexigenic (appetite-stimulating) ghrelin and anorexigenic (appetite-inhibiting) PYY and glucagon-like peptide-1 (GLP-1), and gastrointestinal architecture during pregnancy and lactation, in matched fed and fasted plasma and gut tissue samples taken during the dark phase. Enteroendocrine cells were immunolabelled, and gut masses and lengths were measured. Fasted plasma ghrelin reduced during pregnancy: it was lowest by day 18, recovered to control values at parturition, then increased by the end of lactation. Ghrelin-immunoreactive stomach cells and stomach ghrelin concentrations were highest at birth, prior to the onset of lactation-associated hyperphagia. Plasma fed GLP-1 concentrations were elevated during pregnancy, and together with higher colon concentrations of PYY and GLP-1 during early lactation, they were associated with gastrointestinal tissue expansion, not satiety. Body mass incr...Continue Reading

References

Nov 15, 1979·The Biochemical Journal·K Burdett, C Reek
Jan 1, 1991·Biology of the Neonate·P López-LunaE Herrera
May 1, 1971·The Journal of Physiology·G P Crean, R D Rumsey
Apr 1, 1966·The Journal of Physiology·R BoyneI Robb
May 1, 1996·Gastroenterology·H C LinH Wong
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·D J DruckerP L Brubaker
Jun 1, 1997·The American Journal of Physiology·P L BrubakerD J Drucker
Jul 1, 1997·Journal of Mammary Gland Biology and Neoplasia·K A Hammond
Feb 24, 2001·Nature·M NakazatoS Matsukura
Aug 15, 2001·The Journal of Clinical Endocrinology and Metabolism·M B Toft-NielsenJ J Holst
May 1, 1964·The Journal of Physiology·R M CAMPBELL, B F FELL
Feb 3, 2005·Obesity Research·Sulay A TovarCarlos Diéguez
Apr 28, 2005·Clinical Endocrinology·Jens FuglsangPer Ovesen
Dec 6, 2005·Cell and Tissue Research·Esperanza PujolIsabel Lladó
Jun 15, 2006·The Journal of Clinical Endocrinology and Metabolism·F LevinE Näslund
Aug 10, 2007·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·John R Speakman
Aug 12, 2008·Physiology & Behavior·P W J MaljaarsA A M Masclee
Sep 27, 2008·Endocrinology·Gareth E LimPatricia L Brubaker
Feb 26, 2009·American Journal of Physiology. Endocrinology and Metabolism·Elaine ThamJean-Pierre Chanoine
Feb 10, 2011·Endocrinology·M L TrujilloR Señarís
Jun 24, 2014·Physiology & Behavior·Charlotte C RonveauxHelen E Raybould
Nov 15, 2017·Gut Microbes·Phyllis E MannGiovanni Widmer

❮ Previous
Next ❯

Citations

Nov 28, 2019·Nutrients·Juan FandiñoFederico Mallo
Oct 30, 2020·Nature·Dafni HadjieconomouIrene Miguel-Aliaga

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.